City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

Researcher awarded grant to study promising new HIV therapy

October 18, 2018 | Samantha Bonar

The California Institute for Regenerative Medicine has awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop chimeric antigen receptor (CAR) T cells that can target and kill HIV-infected cells.

Promising Sickle Cell Research Gets Nearly $6MM Boost from CIRM

March 22, 2018 | Michael Easterling

Thanks to a $5.74 million award from the California Institute for Regenerative Medicine, City of Hope’s Joseph Rosenthal, M.D., and his team can advance their research into finding a cure for sickle cell disease.

Gene Therapy Shows Promise for Hemophilia

February 21, 2018 | Katie Neith

City of Hope researcher and professor, Saswati Chatterjee, Ph.D., thinks she may know a way to cure hemophilia A.

City of Hope’s Alpha Clinic Plots ‘the Future of Nursing’

November 3, 2017 | Wayne Lewis

According to a new paper in Stem Cells Translational Medicine, the authors identify the role of a nurse qualified in both patient care and research protocols, the so-called “hybrid nurse” — a homegrown City of Hope innovation — as an important component of their success in the development of the Alpha Clinic.

Joe Gold: Stem Cell Champion

July 13, 2017 | Abe Rosenberg

Joseph Gold, Ph.D., is chief overseer of a sprawling, state-of-the-art manufacturing facility cranking out mass quantities of carefully engineered stem cells aimed at curing the most dangerous and debilitating diseases of our time.

CIRM Symposium: New Developments in Stem Cell Therapies

March 28, 2017 | Michael Easterling

The stories of patients who have benefited from stem cell therapies funded by the California Institute for Regenerative Medicine (CIRM) were the focus of the second symposium of the institute’s Alpha Stem Cell Clinics Network.